SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Grankvist Kjell) "

Search: WFRF:(Grankvist Kjell)

  • Result 61-70 of 189
Sort/group result
   
EnumerationReferenceCoverFind
61.
  •  
62.
  • Jacobsen, Jan, et al. (author)
  • Prognostic importance of serum vascular endothelial growth factor in relation to platelet and leukocyte counts in human renal cell carcinoma
  • 2002
  • In: European Journal of Cancer Prevention. - 0959-8278 .- 1473-5709. ; 11:3, s. 245-252
  • Journal article (peer-reviewed)abstract
    • It has been shown that both serum vascular endothelial growth factor (VEGF) and also platelet counts are associated with survival in renal cell carcinoma (RCC). It is not known, however, whether VEGF in serum relates to the angiogenic activity of the tumour or is derived from circulating blood components. Therefore, the interrelation between serum VEGF, platelet and leukocyte counts compared with health history, clinicopathological findings and outcome was evaluated in patients with RCC. Blood samples were collected before nephrectomy in 161 patients. Serum VEGF165 was assessed by a quantitative ELISA method. Platelet and leukocyte counts were analysed routinely and obtained from medical records. The variables were compared using univariate and multivariate analysis. There were significant correlations between VEGF levels, and platelet (P < 0.001) and leukocyte counts (P < 0.001). Serum VEGF levels, platelet counts, as well as leukocyte counts correlated significantly to stage and grade. Platelet counts were significantly lower in men with medication (P = 0.042), and decreased with age particularly in women (P = 0.001). Age or medication did not affect VEGF levels or leukocyte counts. Both VEGF and platelets gave significant prognostic information in univariate analysis. Using Cox multivariate analysis, VEGF was the last variable to be excluded. Only stage and grade remained as independent prognostic factors. Both VEGF levels and platelet counts gave prognostic information but VEGF was more reliable as predictor of survival in patients with RCC.
  •  
63.
  •  
64.
  • Jacobsen, Jan, 1957- (author)
  • Vascular endothelial growth factor in renal cell carcinoma
  • 2006
  • Doctoral thesis (other academic/artistic)abstract
    • Background. Angiogenesis is essential for tumour growth. Vascular endothelial growth factor (VEGF) and its isoforms were investigated in relation to the clinical course in a large number of patients with renal cell carcinoma (RCC). Methods. RCC subtypes and behaviour were established by clinicopathological criteria and surveillance. VEGF expression was analysed in serum by enzyme-linked immuno-sorbent assay (ELISA) and in tumour tissue by reverse transcription polymerase chain reaction (RT-PCR), immunohistochemistry (IHC), and Western blot (WB). Results. Serum VEGF (S-VEGF) was increased in RCC compared to control group. S-VEGF correlated with tumour stage and grade and was associated with survival in men but not in women. S-VEGF correlated with blood platelet counts, which were inversely correlated to increasing age in women, and they were decreased in chronically medicated patients, particularly in men. In contrast to S-VEGF, platelet counts associated with survival only in patients free of medication and chronic diseases. RT-PCR showed a correlation between VEGF121/VEGF165 mRNA and between VEGF165/VEGF-R1 mRNA. There was no association between different VEGF mRNA isoforms and S-VEGF. Conventional renal cell carcinoma (CRCC) had higher VEGF165, VEGF121, and VEGF-R1 mRNA levels compared with papillary renal cell carcinoma (PRCC). IHC VEGF staining was strong in kidney cortex. Kidney tumour showed a considerable variation in cytoplasmatic VEGF expression, which correlated with tumour size. Although, there was no difference in VEGF expression between the RCC types, VEGF expression was associated with survival only in CRCC. WB showed a strong protein expression of both VEGF189 and VEGF165 in kidney cortex. In kidney tumour, expression of VEGF189 varied the most, VEGF165 less so, and VEGF121 was rarely detected. Both CRCC and PRCC expressed low levels of VEGF189 and VEGF165 compared with kidney cortex. Chromophobe renal cell carcinoma (ChRCC) expressed VEGF189 levels comparable to those from kidney cortex, while VEGF165 was lower. In PRCC and ChRCC, VEGF189 levels correlated inversely with advancing tumour stage, and in PRCC, VEGF165 levels correlated inversely with increasing tumour size. VEGF189 was an independent prognostic factor for survival in patients with PRCC. Conclusions. S-VEGF has a stronger association to progression in RCC than platelet count. CRCC showed high levels of VEGF mRNA isoforms and VEGF-R1 mRNA compared to PRCC. VEGF mRNA isoforms expression decreased with advancing stage. IHC demonstrated VEGF expression in cell cytoplasm related to tumour growth, particular in CRCC. Different VEGF isoform patterns were found in different RCC types. Protein VEGF189 expression was associated with tumour stage and was an independent prognostic factor in PRCC. Protein VEGF165 expression was generally low and had no prognostic value. The trend for decreasing levels of VEGF isoforms in advanced tumour stages may indicate that angiogenic activity is an early event in tumour growth induced by VEGF, but that during later tumour progression the role of VEGF is less clear.
  •  
65.
  •  
66.
  • Janson, Veronica, et al. (author)
  • Acquisition of Cisplatin-resistance in Malignant Mesothelioma Cells Abrogates Na,K(+),2Cl(-;)-cotransport Activity and Cisplatin-induced Early Membrane Blebbing
  • 2008
  • In: Cellular Physiology and Biochemistry. - : S. Karger. - 1015-8987 .- 1421-9778. ; 22:1-4, s. 45-56
  • Journal article (peer-reviewed)abstract
    • AIMS: Resistance mechanisms are important limiting factors in the treatment of solid malignancies with cis-diamminedichloroplatinum(II) (cisplatin). To gain further understanding of the effects of acquired cisplatin-resistance, we compared a human malignant pleural mesothelioma cell line (p31) to a sub-line (p31res1.2) with acquired cisplatin-resistance.METHODS AND RESULTS: The role of Na(+),K(+),2Cl(-)-cotransport (NKCC1) activity in cisplatin-induced morphological changes and acquired cisplatin-resistance was investigated in a time-resolved manner. Acquisition of cisplatin-resistance resulted in markedly reduced NKCC1 activity, absence of cisplatin-induced early membrane blebbing, and increased basal caspase-3 activity. At equitoxic cisplatin concentrations, P31res1.2 cells had a faster activation of caspase-3 than P31 cells, but the end-stage cytotoxicity and number of cells with DNA fragmentation was similar. Bumetanide inhibition of NKCC1 activity in P31 cells repressed cisplatin-induced early-phase membrane blebbing but did not increase P31 cell resistance to cisplatin.CONCLUSIONS: Together, these results suggest that active NKCC1 was necessary for cisplatin-induced early membrane blebbing of P31 cells, but not for cisplatin-resistance. Thus, acquisition of cisplatin-resistance can affect mechanisms that have profound effects on cisplatin-induced morphological changes but are not necessary for the subsequent progression to apoptosis.
  •  
67.
  •  
68.
  • Janson, Veronica, 1974- (author)
  • Cisplatin-resistance and cell death in malignant pleural mesothelioma cells
  • 2008
  • Doctoral thesis (other academic/artistic)abstract
    • Malignant pleural mesothelioma (MPM) is an aggressive, treatment-resistant tumour. Cisplatin (cis-diamminedichloroplatinum (II)) is the best single-agent chemotherapy for MPM, but platinum-based combination therapies give the best overall response rates. However, cisplatin use is limited by resistance and severe side effects. This thesis has increased the knowledge concerning cisplatin-induced cell death in MPM by describing a novel potential therapeutic target, and three novel phenotypes of cisplatin-resistance in a human MPM cell line (P31) and its cisplatin-resistant sub-line (P31res1.2). The novel potential therapeutic target, and one of the novel phenotypes, was cisplatin-resistant pro-apoptotic BH3-only proteins. In the P31 cells, cisplatin transiently increased pro-apoptotic BH3-only proteins during 6 h of exposure. This response was almost completely abrogated in the P31res1.2 cells. De-regulated caspase activity and activation was the second novel phenotype identified. The P31res1.2 cells had earlier, possibly mitochondria-independent, caspase-3 activation, increased basal caspase-3 activity and increased basal cleavage of caspase-8 and -9. Despite these differences, 6-h equitoxic cisplatin exposures rendered 50-60% of the cells apoptotic in both cell lines. The third novel phenotype was abrogated Na+K+2Cl--cotransporter (NKCC1) activity. Although NKCC1 activity was dispensable for cisplatin-induced apoptosis, balanced potassium transport activity was essential for P31 cell survival. Finally, the survival signalling protein Protein Kinase B (PKB or Akt) isoforms α and γ were constitutively activated in a PI3K-independent manner in P31 cells. In the P31res1.2 cells, PKBα and γ activities were increased, and there was PI3K-dependent activation of PKBβ. However, this increase in PKB isoform activity was not strongly associated to the cisplatin-resistance of the P31res1.2 cells.
  •  
69.
  • Janson, Veronica, et al. (author)
  • Phase-contrast microscopy studies of early Cisplatin-induced morphological changes of malignant mesothelioma cells and the correspondence to induced apoptosis
  • 2008
  • In: Experimental Lung Research. - : Taylor & Francis. - 0190-2148 .- 1521-0499. ; 34:2, s. 49-67
  • Journal article (peer-reviewed)abstract
    • Cisplatin treatment efficacy of malignant pleural mesothelioma (MPM) is aggravated by resistance and adverse effects. In P31 MPM cells, cisplatin induces morphological changes and apoptosis. To determine if very early (10 minutes) morphological responses corresponded to apoptosis-induction, cisplatin effects on P31 morphology were examined with phase-contrast microscopy (PCM), scanning electron microscopy (SEM), and flow cytometry (fluorescence-activated cell sorting [FACS]), and compared to apoptosis-induction over time. Increased membrane protrusions were identified with PCM and SEM, but these were not consistent with the induction of apoptosis. The authors concluded that very early morphological changes can be determined with PCM in MPM, but they did not convincingly correspond to apoptosis induction.
  •  
70.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 61-70 of 189
Type of publication
journal article (144)
other publication (15)
doctoral thesis (12)
book chapter (9)
research review (7)
conference paper (2)
show more...
show less...
Type of content
peer-reviewed (157)
other academic/artistic (31)
pop. science, debate, etc. (1)
Author/Editor
Grankvist, Kjell (173)
Johansson, Mikael (43)
Johansson, Mattias (41)
Brennan, Paul (34)
Le Marchand, Loïc (28)
Zeleniuch-Jacquotte, ... (27)
show more...
Amos, Christopher I. (26)
Hung, Rayjean J. (26)
Ljungberg, Börje (24)
Chen, Chu (24)
Field, John K. (24)
Lazarus, Philip (24)
Tardon, Adonina (24)
Bojesen, Stig E. (23)
Kiemeney, Lambertus ... (23)
Risch, Angela (23)
Aldrich, Melinda C (23)
Christiani, David C. (23)
Liu, Geoffrey (23)
Schabath, Matthew B. (23)
Rasmuson, Torgny (22)
Lam, Stephen (21)
Lundin, Eva (20)
Lukanova, Annekatrin (19)
Toniolo, Paolo (19)
Lehtinen, Matti (18)
Behnam Motlagh, Parv ... (18)
Yuan, Jian-Min (18)
Albanes, Demetrius (17)
Brulin, Christine (16)
Shen, Hongbing (16)
Nybo, Mads (16)
Kaaks, Rudolf (15)
Manjer, Jonas (15)
Melander, Olle (15)
Rennert, Gad (15)
Severi, Gianluca (15)
Wichmann, H. Erich (15)
Andrew, Angeline S. (15)
Henriksson, Roger (14)
Brunnström, Hans (14)
Landi, Maria Teresa (14)
Pukkala, Eero (14)
Caporaso, Neil (14)
Zienolddiny, Shanbeh (14)
Lippi, Giuseppe (14)
Simundic, Ana-Maria (14)
Surcel, Helja-Marja (14)
Schock, Helena (14)
Stevens, Victoria L (13)
show less...
University
Umeå University (184)
Lund University (33)
Karolinska Institutet (14)
Linköping University (6)
Uppsala University (5)
University of Gothenburg (1)
Language
English (174)
Swedish (9)
Undefined language (5)
Romanian (1)
Research subject (UKÄ/SCB)
Medical and Health Sciences (132)
Natural sciences (8)
Engineering and Technology (5)
Agricultural Sciences (3)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view